Turning biological variability into consistent outcomes with cell culture vessels
Sponsor
Live30 webinars pack the latest innovations and applications into a data-rich 30-minute session.
Improve consistency in ATMP manufacturing through optimized process design and culture platform selection. This webinar presents Cryovida’s potency index approach to evaluate and compare the functional performance of mesenchymal stromal cell (MSC) batches. This approach supports more consistent batch assessment, enhances process understanding, and bridges the gap between manufacturing data and functional outcomes.
Through Cryovida’s representative case study, the session explores how culture platform selection plays a critical role in process performance and reproducibility. Particular focus is placed on a multilayer cell culture vessel system, highlighting how its design supports improved environmental uniformity, reduced handling variability, and scalable workflows. Under these conditions, the vessel demonstrated more consistent potency profiles compared with conventional multilayer systems and traditional T-flask approaches, reinforcing the importance of controlled process environments in achieving reliable results.
The session also discusses how aligning process design with functional evaluation strategies can reduce variability, strengthen process understanding, and support more reproducible manufacturing. Overall, this webinar provides a practical perspective on how process-driven approaches and structured potency assessment can contribute to more consistent and reliable ATMP manufacturing outcomes.
Attend this webinar to:
- Understand how a structured potency index can be applied to evaluate and compare MSC batch performance, supporting more consistent functional assessment across manufacturing runs
- Examine case study data showing how culture vessel design influences environmental uniformity, handling variability, and potency profile consistency in MSC manufacturing
- Compare performance outcomes across multilayer vessel formats and T-flask approaches, and understand how platform selection affect process reproducibility
- Apply process design principles that align functional evaluation with manufacturing strategy to reduce variability and strengthen process understanding in ATMP development
Warranty / Disclaimer: Unless otherwise specified, all products are for research use or general laboratory use only.* Not intended for use in diagnostic or therapeutic procedures. Not for use in humans. These products are not intended to mitigate the presence of microorganisms on surfaces or in the environment, where such organisms can be deleterious to humans or the environment. Corning Life Sciences makes no claims regarding the performance of these products for clinical or diagnostic applications. *For a listing of US medical devices, regulatory classifications or specific information on claims, visit www.corning.com/resources.
Corning’s products are not specifically designed and tested for diagnostic testing. Many Corning products, though not specific for diagnostic testing, can be used in the workflow and preparation of the test at the customers discretion. Customers may use these products to support their claims. We cannot make any claims or statements that our products are approved for diagnostic testing either directly or indirectly. The customer is responsible for any testing, validation, and/or regulatory submissions that may be required to support the safety and efficacy of their intended application.
SPEAKERS
You might also like
Optimizing upstream cell culture with rapid at-line and in-line analytics
Addressing variability in pathology assessment across global clinical trials
Automating iPSC culture: scalable workflows
